ACE2 and Insulin resistance: It was also shown that the activation of the ACE2/(A1-7)/Mas axis can improve hepatic insulin resistance, increase glucose uptake and decrease glycogen synthesis in the liver (25), therefore ACE2 was suggested to be a novel drug target for treating insulin resistance (26).